CN103845583B - A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis - Google Patents
A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis Download PDFInfo
- Publication number
- CN103845583B CN103845583B CN201410103800.6A CN201410103800A CN103845583B CN 103845583 B CN103845583 B CN 103845583B CN 201410103800 A CN201410103800 A CN 201410103800A CN 103845583 B CN103845583 B CN 103845583B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine preparation
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 58
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 47
- 206010008909 Chronic Hepatitis Diseases 0.000 title claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000004615 ingredient Substances 0.000 claims abstract description 14
- 241000218691 Cupressaceae Species 0.000 claims abstract description 9
- 241000576409 Ligustrum sinense Species 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 238000005202 decontamination Methods 0.000 claims description 6
- 230000003588 decontaminative effect Effects 0.000 claims description 6
- 239000004570 mortar (masonry) Substances 0.000 claims description 6
- -1 boil 2 ~ 3 hours Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 13
- 231100000283 hepatitis Toxicity 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 9
- 241000700605 Viruses Species 0.000 abstract description 6
- 230000003908 liver function Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000005784 autoimmunity Effects 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 12
- 230000036407 pain Effects 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 206010007247 Carbuncle Diseases 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 230000008961 swelling Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 208000014674 injury Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 208000019425 cirrhosis of liver Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000004371 toothache Diseases 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000000472 traumatic effect Effects 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019668 Hepatic fibrosis Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000028659 discharge Diseases 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 229940093181 glucose injection Drugs 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940090044 injection Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- LVBRFZFUCKKGDJ-HJWRJIQTSA-J magnesium;dipotassium;(2s)-2-aminobutanedioate;hydron Chemical compound [Mg+2].[K+].[K+].OC(=O)[C@@H](N)CC([O-])=O.OC(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O LVBRFZFUCKKGDJ-HJWRJIQTSA-J 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229940111263 potassium magnesium aspartate Drugs 0.000 description 1
- ZRHANBBTXQZFSP-UHFFFAOYSA-M potassium;4-amino-3,5,6-trichloropyridine-2-carboxylate Chemical compound [K+].NC1=C(Cl)C(Cl)=NC(C([O-])=O)=C1Cl ZRHANBBTXQZFSP-UHFFFAOYSA-M 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis, belong to the field of Chinese medicines, the raw material of Chinese medicine preparation effective ingredient of the present invention consists of: Folium Malloti Apeltae, Herba stellariae mediae, Herba Xanthii, Herba senecionis nemorensis, Spora Lygodii, Radix Bupleuri, Fructus Schisandrae Chinensis, Herba Apii graveolentis, river cypress, Rhizoma Paridis, Herba Dichodrae, Maifanitum, Rhizoma Curculiginis, ligustrum sinense, Radix Achyranthis Bidentatae and Bulbus Allii Macrostemonis; Chinese medicine preparation of the present invention selects Chinese crude drug to be raw material, compatibility meets Chinese medicine and modern medicine and pharmacology research theory has, tool dispersing the stagnated live-QI to relieve the stagnation of QI, benefiting QI and nourishing blood, keep fit effect of liver, improve body autoimmunity, suppress and eliminate hepatitis virus, recovering liver function, short treating period instant effect, there is the curative effect for the treatment of both the principal and secondary aspects of a disease, the clinical treatment of chronic hepatitis can be widely used in.
Description
Art
The present invention relates to the field of Chinese medicines, particularly relate to a kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis.
Background technology
Chronic hepatitis refers to and is caused by different pathogeny, and the course of disease is at least continued above hepatic necrosis and the inflammation of more than 6 months, and as infected hepatitis virus (hepatitis B virus, hepatitis C virus), long-term alcohol, takes hepatotoxic medication etc.Corresponding symptom, sign regulating liver-QI biochemical analysis can be had clinically abnormal, also can without obvious clinical symptoms, only there are necrosis and the inflammation of hepatic tissue, necrosis of liver tissue in various degree and inflammatory reaction, there is hepatic fibrosis subsequently, the course of disease is undulatory property or lasting Progressive symmetric erythrokeratodermia, if do not carried out suitable treatment, finally can develop into liver cirrhosis.
The early symptom of classic chronic hepatitis is slight and lack specificity, intermittent in undulatory property, even for many years without any symptom.Modal is exactly easy tired and stomach discomfort, and be easily left in the basket, being also easily mistaken as is gastropathy; Often see invisible liver cirrhosis patient clinically, before there is liver cirrhosis, do not feel significant discomfort, also do not carry out conventional health check-up, progressively developing into liver cirrhosis unconsciously; Occasionally there is patient to occur feeling sick, abdominal distention, jaundice, urine color depth, but the order of severity of chronic hepatitis can not be judged according to symptom.
Severely chronic hepatitis and chronic severe hepatitis, when Urinary color Progressive symmetric erythrokeratodermia is deepened, skin yellow sclera Progressive symmetric erythrokeratodermia is deepened, when weak appetite declines more and more obviously, sb.'s illness took a turn for the worse in prompting, especially needs the generation of vigilant chronic severe hepatitis, chronic severe hepatitis is the performance of liver failure, can show as highly weak, height abdominal distention, height jaundice and height inappetence, hypoproteinemia can be there is, ascites hydrothorax, abdominal cavity infection, coagulation function declines, upper gastrointestinal hemorrhage, hepatic encephalopathies etc., mortality rate is higher clinically, needs actively to give treatment to.
Chronic hepatitis complication is comparatively general, as chronic cholecystitis, and hepatogenous diabetes, HBV-associated nephropathy etc.On the basis of chronic hepatitis, when having that inducement is as overworked in patient, heavy drinking or other hepatitis viruss of superinfection time, state of an illness sharp deterioration can be there is, develop into chronic severe hepatitis.
, there is the deficiency of two aspects in the field of Chinese medicines of current treatment chronic hepatitis: one is that effect is obvious not, two be take effect slower.So that large quantities of chronic hepatitis patient is because can not get the treatment of active drug, liver disease development, clinical symptoms can not get alleviating, patient is long-term, and seriously weak, dull pain in liver, liver function decline, hepatic fibrosis is serious, in the treatment of this type of medicine, effect is obvious not, take effect slower problem, and the Chinese medicine therefore researching and developing a kind of safe and effective treatment chronic hepatitis becomes the emphasis of modern medicine study.
Summary of the invention
The invention provides a kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis; Chinese medicine preparation of the present invention selects Chinese crude drug to be raw material, compatibility meets Chinese medicine and modern medicine and pharmacology research theory has, tool dispersing the stagnated live-QI to relieve the stagnation of QI, benefiting QI and nourishing blood, keep fit effect of liver, improve body autoimmunity, suppress and eliminate hepatitis virus, recovering liver function, short treating period instant effect, there is the curative effect for the treatment of both the principal and secondary aspects of a disease, the clinical treatment of chronic hepatitis can be widely used in.
For achieving the above object, technical scheme of the present invention is implemented as follows:
Treat a Chinese medicine preparation for chronic hepatitis, raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Treat a preparation method for the Chinese medicine preparation of chronic hepatitis, comprise following processing step:
(1) Folium Malloti Apeltae, Herba Xanthii, Herba senecionis nemorensis, Spora Lygodii, Fructus Schisandrae Chinensis, Rhizoma Paridis, Herba Dichodrae, ligustrum sinense and Radix Achyranthis Bidentatae are cleaned, put into container, add the distilled water of 8 ~ 12 times amount, soak after 4 ~ 5 hours, boil 3 ~ 4 hours, extract; Again add 6 ~ 8 times amount distilled water, boil 2 ~ 3 hours, extract; Finally, add 4 ~ 6 times amount distilled water, heated and boiled 1 ~ 2 hour, extract; Merge three extracting solution, filter, obtain filtrate, being condensed into relative density at 50 DEG C is the thick paste of 1.10 ~ 1.14, for subsequent use;
(2) Herba stellariae mediae, Herba Apii graveolentis and Bulbus Allii Macrostemonis are cleaned, chopping, puts into container, strand juice, and filter impurity, stays juice for subsequent use;
(3) by Radix Bupleuri decontamination, clean, section, dries, is placed in container, mixes thoroughly with vinegar, puts in pot to fry with slow fire to exhaust and micro-dry to vinegar, takes out, dries, be placed in mortar, grind into powder, cross 180 order fine powders for subsequent use;
(4) river cypress, Maifanitum and Rhizoma Curculiginis decontamination are dried, be placed in mortar and grind into powder, cross 160 order fine powders, for subsequent use;
(5) made for above-mentioned steps (1) ~ (4) thick paste, juice and fine powder are mixed, make capsule, both the Chinese medicine preparation for the treatment of chronic hepatitis of the present invention.
The property of medicine of the present invention's Chinese medicine used is as follows:
Folium Malloti Apeltae: mildly bitter flavor, puckery, property is put down.Easing the affected liver is invigorated blood circulation, invigorating the spleen for eliminating dampness, solid de-, the anti-inflammation hemostasia of convergence.For chronic hepatitis, hepatosplenomegaly, uterine prolapse, proctoptosis, leucorrhea, edema during pregnancy; Otitis media is controlled in external, furuncle and phyma, traumatic injury, traumatic hemorrhage." Nanning City's medicine will " carries: " heat clearing away, diuretic, wind-damp dispelling, pain relieving.Control stranguria with turbid discharge, hemorrhoid, traumatic injury, snakebite.Antipruritic, detumescence.”
Herba stellariae mediae: mildly bitter flavor, sweet, sour, cool in nature; Return liver, large intestine channel.Heat-clearing and toxic substances removing, blood-activating analgetic, lactogenic.For enteritis, dysentery, hepatitis, appendicitis, postnatal blood stasis is suffered from abdominal pain, uterine contraction pain, toothache, early whitening of hair, agalactia, mastitis, traumatic injury, sore swollen toxin." illustrated handbook planted by middle traditional Chinese medicines " carries: " leave rubs juice, and skin ulcer wound is controlled in external; Stem and leaf is mixed salt and is stung it, can control toothache; Vinegar and, or charred medicinal herb with its property retained Oleum Sesami dresses skin ulcer and toxic swelling.”
Herba Xanthii: bitter in the mouth, pungent, cold nature, mild toxicity; Return lung, spleen, Liver Channel.Wind and heat eliminating, removing dampness and detoxicating.Cure mainly flu, wind syndrome of head, dizzy, nasal sinusitis, conjunctival congestion, corneal nebula, pathogenic wind-warm arthralgia pain, contracture numbness, wind leprosy, furuncle, scabies, skin pruritus, hemorrhoid, dysentery etc." Guangdong Chinese medicine " carries: " control red cloud blood tinea, phlegm-fire core, flu, nasal sinusitis.”
Herba senecionis nemorensis: bitter in the mouth is pungent, cold in nature; Enter liver, spleen channel.Heat-clearing and toxic substances removing.Cure mainly dysentery, enteritis, hepatitis, conjunctivitis, otitis media, carbuncle treats poison, swelling around the eyes, carbuncle furuncle furunculosis.
Spora Lygodii: sweet in the mouth, cold in nature; Return bladder, small intestine meridian.Eliminating damp-heat, treating stranguria pain relieving.Cure mainly urinary tract infection, lithangiuria, nebulousurine, leucorrhea, hepatitis, oedema due to nephritis, laryngopharynx swelling and pain, mumps, enteritis, dysentery, skin eczema, herpes zoster." Jiangxi medical herbs " carries, " heat-clearing and toxic substances removing, promoting urination to remove dampness.Treating the liver is scorching, renal edema, skin eczema, chickenpox, hematuria.Mumps, acute toothache, throat moth, diphtheria, herpes zoster, children's L infantile malnutrition ".
Radix Bupleuri: bitter in the mouth, pungent, cold nature; Return liver, gallbladder meridian.Depressed liver-energy dispersing and function of gallbladder promoting, dredge gas resolving depression, expelling pathogenic factors from the exterior expels the heat-evil, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.Cure mainly cold, fever, cold and heat deficient fever, children's's varioliform exanthema waste heat, emaciation and sallow complexion abdominal part expands, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, and uterus comes off, menoxenia.Modern medicine study confirms, the heating of Radix Bupleuri decoct has obvious refrigeration function, all has inhibitory action to the inflammation caused by multiple proinflammatory agent, and can Promote immunity function.
Fructus Schisandrae Chinensis: sour in the mouth, sweet, warm in nature; Return lung, the heart, kidney channel.To astringe the lung nourishing kidney, receipts of promoting the production of body fluid antiperspirant, arresting seminal emission.Modern medicine study confirms, Fructus Schisandrae Chinensis can protect human five internal organs's heart, liver, spleen, lung, kidney, and the strong liver of energy QI invigorating, the detoxification processes promoting liver, the liver protecting are from murder by poisoning, and the liver organization of energy regeneration of damaged.The strong liver of energy QI invigorating, the efficiency of promoting cells exclude refuse, supply more oxygen, construction and utilization energy.
Herba Apii graveolentis: sweet in the mouth, pungent, cool in nature; Enter liver, gallbladder, pericardium channel.Suppressing the hyperactive liver stomach invigorating, liver heat removing profit blood, expelling wind and removing dampness.Cure mainly hypertension, dizziness and headache, flushing conjunctival congestion, stranguria with blood, carbuncle." book on Chinese herbal medicine pushes away old " carries: " treating the liver sun is dizzy.Flushing conjunctival congestion, top-heavy, walking such as to be swayed the disease." modern medicine study confirmation, Herba Apii graveolentis contains abundant vitamin A, vitamin B1, vitamin B2, vitamin C and Citrin, calcium, ferrum, and the content of mineral substances such as phosphorus are also many, also has the compositions such as protein, mannitol and dietary fiber in addition.
River cypress: bitter in the mouth, cold in nature; Enter kidney, urinary bladder channel.Heat clearing and damp drying, eliminating fire and detoxication.Cure mainly hematodiarrhoea, have loose bowels, quench one's thirst, jaundice ， flaccidity of feet with lamenness, nocturnal emission, stranguria with turbid discharge, hemorrhoid, have blood in stool, also under leucorrhea, and hectic fever due to YIN-deficiency consumptive fever, conjunctival congestion and swelling pain, aphtha of the mouth and tongue, sore swollen toxin.Carry according to " Japan hanako materia medica ": " feel at ease, except labor, to control hectic fever due to YIN-deficiency, liver of waking up, improving eyesight, many tear, xerostomia, heat in the heart, kill infantile malnutrition worm, control ascarid pained, scabies, processed with honey controls serious epistaxis, and hemorrhoidal hamorrhage rushes down blood, and rear point anxious heat swells and ache.”
Rhizoma Paridis: bitter in the mouth, cool in nature, mild toxicity; GUIXIN, liver, lung, stomach, large intestine channel.Heat-clearing and toxic substances removing, reducing swelling and alleviating pain, cool liver arresting convulsion.Cure mainly carbuncle sore tumefacting virus, pharyngeal swelling sore throat, acute mastitis, snake bite and insect sting, traumatic pain, liver-heat is twitched.Modern medicine study confirms, Rhizoma Paridis has good result to woman's galactostasis of managing property.
Herba Dichodrae: acrid in the mouth, property is put down.Clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling.For hepatitis, cholecystitis, dysentery, oedema due to nephritis, urinary system infection, urinary system calculus, tonsillitis, traumatic injury.
Maifanitum: sweet in the mouth, warm in nature, nontoxic; Return liver, stomach, kidney channel.Detoxicating and resolving stagnation of pathogens, removing the necrotic tissue and promoting granulation, except cold damp eliminating, the liver benefiting stomach invigorating, blood circulation promoting and blood stasis dispelling, diuresis fossil.Cure mainly carbuncle carbuncle on the back, acne, eczema, beriberi, miliaria, finger is chapped, chloasma, toothache, oral ulcer, rheumatic arthralgia, lumbago and backache, chronic hepatitis, gastritis, dysentery, diabetes, neurasthenia, wound is red and swollen, hypertension, senile sclerosis of blood vessels, tumor, lithangiuria.
Rhizoma Curculiginis: acrid in the mouth, hot in nature, poisonous; Return kidney,liver,spleen warp.Kidney-replenishing, bone and muscle strengthening, dispelling cold and dampness.For sexual impotence cold sperm, muscles and bones flaccidity is soft, the cold numbness of waist knee joint, yang deficiency cold diarrhea." the southern regions of the Yunnan Province book on Chinese herbal medicine " carries: " control that married woman is red collapses hematochezia, attack carbuncle, evacuation of pus.”
Ligustrum sinense: bitter in the mouth, cold in nature.Heat-clearing and toxic substances removing, bacteriostasis and sterilization, reducing swelling and alleviating pain, putrefaction-removing granulation-promoting, for acute icteric infectious hepatitis, dysentery, cough due to lung-heat; Traumatic injury is controlled in external, traumatic infection, burn and scald, the surgical infection diseases such as sore swollen toxin.
Radix Achyranthis Bidentatae: bitter in the mouth, acid, property is put down; Return liver, kidney channel.Invigorating the liver and kidney, bone and muscle strengthening, promoting blood circulation to restore menstrual flow, ignites descending, inducing diuresis for treating stranguria syndrome.Cure mainly soreness of waist and knee joint, flaccidity and weakness of the lower limbs, amenorrhea due to stagnation of blood, dysmenorrhea, puerperal abdominal pain due to blood stasis, lump in the abdomen, retention of placenta, pyretic stranguria, stranguria with blood, traumatic injury, carbuncle malignant boil, laryngopharynx swelling and pain." detailed outline " carries: " control chronic malaria cold and heat, five types of stranguria hematuria, pains in the penis, dysentery, sore throat, aphtha, toothache, carbuncle malignant boil, traumatics fracture." modern medicine study confirmation, Radix Achyranthis Bidentatae has good protein assimilation and anti-inflammatory and analgesic effect.
Bulbus Allii Macrostemonis: acrid in the mouth, hardship, warm in nature; Return lung, the heart, stomach, large intestine channel.To regulate the flow of vital energy the chest stuffiness relieving, activating YANG and eliminating stagnation.Cure mainly the thorough back of the body of obstruction of qi in the chest and cardialgia, breast gastral cavity painful abdominal mass is vexed, cough with asthma abundant expectoration, epigastric pain, heavy after letting out dysentery, leucorrhea, furuncle carbuncle.Modern medicine study confirms, Bulbus Allii Macrostemonis water decoction has inhibitory action to dysentery bacterium, staphylococcus aureus, and 300% water decoction tube dilution method, 1:4 has inhibitory action to staphylococcus aureus, streptococcus pneumoniae, has inhibitory action during 1:16 to sarcina.
The present invention compared with prior art, has following beneficial effect:
Chinese medicine preparation of the present invention selects Chinese crude drug to be raw material, compatibility meets Chinese medicine and modern medicine and pharmacology research theory has, tool dispersing the stagnated live-QI to relieve the stagnation of QI, benefiting QI and nourishing blood, keep fit effect of liver, improve body autoimmunity, suppress and eliminate hepatitis virus, recovering liver function, short treating period instant effect, there is the curative effect for the treatment of both the principal and secondary aspects of a disease, the clinical treatment of chronic hepatitis can be widely used in.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further elaborated.
Embodiment 1
The raw material composition of Chinese medicine preparation effective ingredient of the present invention and weight are:
Treat a preparation method for the Chinese medicine preparation of chronic hepatitis, comprise following processing step:
(1) Folium Malloti Apeltae, Herba Xanthii, Herba senecionis nemorensis, Spora Lygodii, Fructus Schisandrae Chinensis, Rhizoma Paridis, Herba Dichodrae, ligustrum sinense and Radix Achyranthis Bidentatae are cleaned, put into container, add the distilled water of 8 ~ 12 times amount, soak after 4 ~ 5 hours, boil 3 ~ 4 hours, extract; Again add 6 ~ 8 times amount distilled water, boil 2 ~ 3 hours, extract; Finally, add 4 ~ 6 times amount distilled water, heated and boiled 1 ~ 2 hour, extract; Merge three extracting solution, filter, obtain filtrate, being condensed into relative density at 50 DEG C is the thick paste of 1.10 ~ 1.14, for subsequent use;
(2) Herba stellariae mediae, Herba Apii graveolentis and Bulbus Allii Macrostemonis are cleaned, chopping, puts into container, strand juice, and filter impurity, stays juice for subsequent use;
(3) by Radix Bupleuri decontamination, clean, section, dries, is placed in container, mixes thoroughly with vinegar, puts in pot to fry with slow fire to exhaust and micro-dry to vinegar, takes out, dries, be placed in mortar, grind into powder, cross 180 order fine powders for subsequent use;
(4) river cypress, Maifanitum and Rhizoma Curculiginis decontamination are dried, be placed in mortar and grind into powder, cross 160 order fine powders, for subsequent use;
(5) made for above-mentioned steps (1) ~ (4) thick paste, juice and fine powder are mixed, make capsule, both the Chinese medicine preparation for the treatment of chronic hepatitis of the present invention.
Usage and dosage: oral, every day 2 times, each 2, warm water delivery service after meal; Within 10 days, be 1 course for the treatment of, 3 ~ 4 courses for the treatment of can fully recover, and the person of being in a bad way follows the doctor's advice.
Embodiment 2
The raw material composition of Chinese medicine preparation effective ingredient of the present invention and weight are:
The Chinese medicine preparation preparation method processing step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 3
The raw material composition of Chinese medicine preparation effective ingredient of the present invention and weight are:
The Chinese medicine preparation preparation method processing step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 4
The raw material composition of Chinese medicine preparation effective ingredient of the present invention and weight are:
The Chinese medicine preparation preparation method processing step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 5
The raw material composition of Chinese medicine preparation effective ingredient of the present invention and weight are:
The Chinese medicine preparation preparation method processing step of the present embodiment and usage and dosage identical with embodiment 1.
Clinical data:
1, case selection:
As the Chinese medicine preparation for the treatment of chronic hepatitis, select the routine clinical observation of chronic hepatitis patient 400 of making a definite diagnosis.
Patient is divided into treatment group and matched group two groups at random, treatment group 200 example, wherein male 105 example, women 95 example, 30 ~ 62 years old age, 45.5 years old mean age, the shortest person of the course of disease 2 months, most elder 5 years, average 2.8 years; Matched group 200 example, wherein male 104 example, women 96 example, 31 ~ 63 years old age, 46.5 years old mean age, the shortest person of the course of disease 3 months, most elder 6 years, average 3.1 years.
The course of disease, the degrees of symptoms for the treatment of group and matched group two groups of cases are basically identical, without significant difference, have comparability.
2, Chinese medicine preparation is selected:
Treatment group takes Chinese medicine preparation of the present invention, oral, every day 2 times, each 2, warm water delivery service after meal; Within 10 days, be 1 course for the treatment of, take 3 ~ 4 courses for the treatment of continuously, the person of being in a bad way follows the doctor's advice.
Matched group injection potassium magnesium aspartate and glucose injection, intravenous drip, a 10 ~ 20ml, adds in 5% glucose injection 500ml and slowly instils, every day 1 time, or follows the doctor's advice; Within 20 days, be 1 course for the treatment of, treat 2 courses for the treatment of continuously, the person of being in a bad way follows the doctor's advice.
3, efficacy determination:
(1) cure: patient clinical symptom all disappears, liver function recovery is normal, and health indices recovers normal on inspection.
(2) effective: patient clinical symptom major part disappears, and health indices raises all to some extent on inspection.
(3) effective: patient clinical symptom is slightly good, and health indices all increases on inspection.
(4) invalid: by treating rear clinical symptoms without significant change.
4, result:
Select in the treatment group of Chinese medicine preparation of the present invention, cure 80 examples, effective 72 examples, effective 45 examples, invalid 3 examples, cure rate 40%, total effective rate 98.5%.
40 examples are cured, effective 50 examples, effective 30 examples, invalid 80 examples, cure rate 20%, total effective rate 60% in matched group.
Above result display, the cure rate for the treatment of group and total effective rate are apparently higher than matched group.
Model case is illustrated:
1, what certain, man, 35 years old, people from Dalian.The long-term anorexia of patient, weak, complexion yellowish-brown simple and unadorned, color of the lip is dark violet, remove examination in hospital, it is early stage that laboratory test report is shown as chronic hepatitis, after taking 1 course for the treatment of of Chinese medicine preparation of the present invention, above-mentioned symptom fades away, and after taking 3 courses for the treatment of of Chinese medicine preparation of the present invention, cures, again chemically examine, laboratory test report display liver function recovery is normal.
2, Lee, female, 42 years old, people from Liaoyuan, Jilin.Patient suffers from acute jaundice chronic hepatitis, the mobility of thrombinogen is lower than 40%, serum bilirubin and alaninyl transferring enzyme high, take multi-medicament treatment all without positive effect, rear beginning takes medicine Chinese medicine preparation of the present invention, after taking 4 courses for the treatment of, the mobility of thrombinogen, serum bilirubin and alaninyl transferring enzyme all recover normal value, no longer recur after healing, follow up a case by regular visits to, do not recur again so far.
3, high certain, man, 51 years old, Yancheng, Jiangsu Province people.Patient's suffering from liver cirrhosis, xerosis cutis is coarse, and complexion is gloomy, and to have vomiting and diarrhoea, and be even unable to leave the bed, through multi-treatment all without onset, patient is close to despair.To our hospital afterwards, after taking 1 course for the treatment of of Chinese medicine preparation of the present invention, the state of an illness is obviously suppressed, and can do some daily housework, after taking 2 courses for the treatment of of Chinese medicine preparation of the present invention, curing, recovers as ordinary person, following up a case by regular visits to after 1 year without recurring.
Claims (5)
1. treat a Chinese medicine preparation for chronic hepatitis, it is characterized in that: raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Folium Malloti Apeltae 43 ~ 73 parts of Herba stellariae mediaes 33 ~ 63 portions of Herba Xanthiis 33 ~ 63 parts of Herba senecionis nemorensis 33 ~ 58 parts
Spora Lygodii 28 ~ 58 parts of Radix Bupleuri 28 ~ 53 parts of Fructus Schisandrae Chinensis 23 ~ 53 portions of Herba Apii graveolentis 23 ~ 48 parts
River cypress 23 ~ 48 parts of Rhizoma Paridis 18 ~ 48 parts of Herba Dichodraees 18 ~ 48 parts of Maifanitums 13 ~ 48 parts
Rhizoma Curculiginis 13 ~ 43 parts of ligustrum sinenses 11 ~ 43 parts of Radix Achyranthis Bidentataes 11 ~ 38 parts of Bulbus Allii Macrostemonis 9 ~ 33 parts.
2. a kind of Chinese medicine preparation for the treatment of chronic hepatitis according to claim 1, is characterized in that: raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Folium Malloti Apeltae 48 ~ 68 parts of Herba stellariae mediaes 38 ~ 58 portions of Herba Xanthiis 38 ~ 58 parts of Herba senecionis nemorensis 37 ~ 54 parts
Spora Lygodii 33 ~ 53 parts of Radix Bupleuri 32 ~ 49 parts of Fructus Schisandrae Chinensis 28 ~ 48 portions of Herba Apii graveolentis 27 ~ 44 parts
River cypress 27 ~ 44 parts of Rhizoma Paridis 23 ~ 43 parts of Herba Dichodraees 23 ~ 43 parts of Maifanitums 19 ~ 42 parts
Rhizoma Curculiginis 18 ~ 38 parts of ligustrum sinenses 16 ~ 38 parts of Radix Achyranthis Bidentataes 15 ~ 34 parts of Bulbus Allii Macrostemonis 13 ~ 29 parts.
3. a kind of Chinese medicine preparation for the treatment of chronic hepatitis according to claim 1, is characterized in that: raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Folium Malloti Apeltae 53 ~ 63 parts of Herba stellariae mediaes 43 ~ 53 portions of Herba Xanthiis 43 ~ 53 parts of Herba senecionis nemorensis 41 ~ 50 parts
Spora Lygodii 38 ~ 48 parts of Radix Bupleuri 36 ~ 45 parts of Fructus Schisandrae Chinensis 33 ~ 43 portions of Herba Apii graveolentis 31 ~ 40 parts
River cypress 31 ~ 40 parts of Rhizoma Paridis 28 ~ 38 parts of Herba Dichodraees 28 ~ 38 parts of Maifanitums 25 ~ 36 parts
Rhizoma Curculiginis 23 ~ 33 parts of ligustrum sinenses 21 ~ 33 parts of Radix Achyranthis Bidentataes 19 ~ 30 parts of Bulbus Allii Macrostemonis 17 ~ 25 parts.
4. a kind of Chinese medicine preparation for the treatment of chronic hepatitis according to claim 1, is characterized in that: raw material composition and the parts by weight of making described Chinese medicine preparation effective ingredient are:
Folium Malloti Apeltae 58 parts of Herba stellariae mediaes 48 portions of Herba Xanthiis 48 parts of Herba senecionis nemorensis 46 parts
Spora Lygodii 43 parts of Radix Bupleuri 41 parts of Fructus Schisandrae Chinensis 38 portions of Herba Apii graveolentis 36 parts
River cypress 36 parts of Rhizoma Paridis 33 parts of Herba Dichodraees 33 parts of Maifanitums 31 parts
Rhizoma Curculiginis 28 parts of ligustrum sinenses 27 parts of Radix Achyranthis Bidentataes 24 parts of Bulbus Allii Macrostemonis 21 parts.
5. as described in any one of Claims 1 to 4, treat a preparation method for the Chinese medicine preparation of chronic hepatitis, it is characterized in that: comprise following processing step:
(1) Folium Malloti Apeltae, Herba Xanthii, Herba senecionis nemorensis, Spora Lygodii, Fructus Schisandrae Chinensis, Rhizoma Paridis, Herba Dichodrae, ligustrum sinense and Radix Achyranthis Bidentatae are cleaned, put into container, add the distilled water of 8 ~ 12 times amount, soak after 4 ~ 5 hours, boil 3 ~ 4 hours, extract; Again add 6 ~ 8 times amount distilled water, boil 2 ~ 3 hours, extract; Finally, add 4 ~ 6 times amount distilled water, heated and boiled 1 ~ 2 hour, extract; Merge three extracting solution, filter, obtain filtrate, being condensed into relative density at 50 DEG C is the thick paste of 1.10 ~ 1.14, for subsequent use;
(2) Herba stellariae mediae, Herba Apii graveolentis and Bulbus Allii Macrostemonis are cleaned, chopping, puts into container, strand juice, and filter impurity, stays juice for subsequent use;
(3) by Radix Bupleuri decontamination, clean, section, dries, is placed in container, mixes thoroughly with vinegar, puts in pot to fry with slow fire to exhaust and micro-dry to vinegar, takes out, dries, be placed in mortar, grind into powder, must be 180 object fine powders for subsequent use;
(4) river cypress, Maifanitum and Rhizoma Curculiginis decontamination are dried, be placed in mortar and grind into powder, 160 object fine powders must be, for subsequent use;
(5) made for above-mentioned steps (1) ~ (4) thick paste, juice and fine powder are mixed, make capsule, obtain the Chinese medicine preparation of described treatment chronic hepatitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410103800.6A CN103845583B (en) | 2014-03-19 | 2014-03-19 | A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410103800.6A CN103845583B (en) | 2014-03-19 | 2014-03-19 | A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103845583A CN103845583A (en) | 2014-06-11 |
| CN103845583B true CN103845583B (en) | 2016-03-30 |
Family
ID=50853987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410103800.6A Expired - Fee Related CN103845583B (en) | 2014-03-19 | 2014-03-19 | A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103845583B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497508A (en) * | 2014-11-07 | 2016-04-20 | 苏珉 | Traditional Chinese medicine for treating chronic hepatitis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393857A (en) * | 2013-08-19 | 2013-11-20 | 张成娟 | Drug for curing hepatitis and preparation method thereof |
-
2014
- 2014-03-19 CN CN201410103800.6A patent/CN103845583B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393857A (en) * | 2013-08-19 | 2013-11-20 | 张成娟 | Drug for curing hepatitis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103845583A (en) | 2014-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520461B (en) | Medicine for treating allergic rhinitis | |
| CN104940727A (en) | Paste for treating rhinitis and preparation method thereof | |
| CN103705751B (en) | Chinese medicine composition being used for the treatment of lumbago due to pathogenic wind-dampness and preparation method thereof | |
| CN104258151A (en) | Drug for treating nephropyelitis and preparation method thereof | |
| CN105535371A (en) | Traditional Chinese medicine for treating gonarthromeningitis | |
| CN101607011B (en) | Traditional Chinese medicine for treating cholecystitis post-operative complacation | |
| CN104383336B (en) | A kind of Chinese medicine preparation for renal calculus postoperative care and preparation method | |
| CN103893611B (en) | A kind of medicine and preparation method who treats kidney stone | |
| CN104161823B (en) | A kind of Chinese medicine for the treatment of aseptic necrosis of femoral head | |
| CN103432485B (en) | Chinese medicinal preparation for treating urinary calculus and preparation method | |
| CN103845583B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis | |
| CN104383384A (en) | Traditional Chinese medicine washing liquid for treating tinea of feet and hands | |
| CN103920044A (en) | Medicine for treating urethral calculus and preparation method thereof | |
| CN103920046A (en) | Medicine for treating cystitis and preparation method thereof | |
| CN103877457B (en) | Chinese medicinal preparation for treating renal calculus and preparation method thereof | |
| CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
| CN104547384A (en) | Oral liquid for treating paraquat poisoning and preparation method of oral liquid | |
| CN104398927A (en) | Traditional Chinese medicinal preparation for treating gonarthromeningitis | |
| CN103432418B (en) | Chinese medicine composition of a kind of gout pain relieving and its production and use | |
| CN103285182B (en) | External-use ointment for treating skin diseases and preparation method thereof | |
| CN107496765A (en) | It is a kind of effectively to treat Chinese medicine composition of acute pancreatitis and preparation method thereof | |
| CN103263586B (en) | Traditional Chinese medicinal composition for treating mycotic enteritis | |
| CN105106590A (en) | Medicine for treating allergic rhinitis | |
| CN105362786A (en) | Traditional Chinese medicine capsules for treating gall-stone and preparation method thereof | |
| CN105055687A (en) | Medicine for treating appendicitis and preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Yanyun Inventor before: Zhang Jilian Inventor before: Yu Yanxia |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20170830 Address after: Yonghong road quarry in Zhangjiakou city of Hebei province building 075000 Huailai County town of Sha 2 unit 401 room Patentee after: Li Yanyun Address before: 262700 Center Health Center, Hou Zhen, Shouguang City, Shandong, Weifang Patentee before: Zhang Jilian |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180524 Address after: 511400 shop on the first floor of the star complex on the south side of the arch bridge in Panyu District, Shi Lou, Panyu District, Guangzhou, A4-A8 Patentee after: Han Fang medical science and Technology (Guangzhou) Co., Ltd. Address before: 075000 Room 401, unit 2, family building, Yonghong road quarry, Sha town, Huailai, Zhangjiakou, Hebei Patentee before: Li Yanyun |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160330 Termination date: 20190319 |